| GWAS |
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885
)
- Body mass index ( 22446040
)
- Breast cancer ( 17903305
)
- Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes ( 29221444
)
- Forehead morphology ( 29921221
)
- Generalized epilepsy ( 30531953
)
- Glucocorticoid-induced osteonecrosis ( 26265699
)
- HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction ( 31806883
)
- Hepatocellular carcinoma ( 22807686
)
- Hyperactive-impulsive symptoms ( 18821565
)
- Lung cancer ( 34062886
)
- Periodontitis (DPAL) ( 24024966
)
- Plasma parathyroid hormone levels ( 30134803
)
- Refractive error ( 32231278
)
- Response to statin therapy ( 20339536
)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027
)
|
- A body shape index ( 34021172
)
- Age-related cognitive decline (language) (slope of z-scores) ( 30954325
)
- Biochemical measures ( 19260141
)
- Cardiac hypertrophy ( 21348951
)
- Cerebral amyloid angiopathy x APOEe4 status interaction in Alzheimer’s disease ( 34020725
)
- Emphysema imaging phenotypes ( 26030696
)
- Heart rate response to recovery post exercise (20 sec) ( 29497042
)
- Longevity (90 years and older) ( 25199915
)
- Obesity-related traits ( 23251661
)
- Obsessive-compulsive disorder ( 22889921
)
- Palmitic acid (16:0) levels ( 23362303
)
- Pursuit maintenance gain ( 29064472
)
- Renal function-related traits (eGRFcrea) ( 22797727
)
- Triglyceride levels x SSRI defined daily dose interaction in schizophrenia or bipolar disorder ( 33824429
)
- Waist circumference adjusted for body mass index ( 34021172
)
- Weight ( 28552196
)
|
